Literature DB >> 7474160

The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame.

G Decaussin1, V Leclerc, T Ooka.   

Abstract

In Epstein-Barr virus (EBV)-carrying nonproducer Raji cells, the induction of the viral replicative cycle by chemical treatment is limited to only the early stage and viral DNA synthesis is totally inhibited. We previously showed the absence of two messenger RNAs that are encoded by the BamHI-A fragment of the EBV genome and that correspond to open reading frames BALF2 and BARF1 in chemically induced Raji cells. Since the BALF2 gene encodes a 135-kDa DNA-binding protein which was immunoprecipitated by antibody against ICP8 protein, a key protein in herpes simplex virus replication, we asked whether the lack of productive cycle in Raji cells is due to the absence of expression of the BALF2 gene. We transfected the Raji cell line with the BALF2 gene. After chemical induction, the BALF2-transfected cells expressed not only early antigens but also late antigens. In these cultures, the viral particles were detected by electron microscopy. The expression of late antigens was completely inhibited by arabinofuranosylthymine, which is a specific inhibitor of viral DNA replication. The BALF2 gene might play an essential role in the induction of the EBV-lytic cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474160      PMCID: PMC189660     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  DNA-binding proteins of cells infected by herpes simplex virus type 1 and type 2.

Authors:  K L Powell; D J Purifoy
Journal:  Intervirology       Date:  1976       Impact factor: 1.763

2.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells.

Authors:  F Toneguzzo; A C Hayday; A Keating
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

6.  Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji.

Authors:  A Polack; H Delius; U Zimber; G W Bornkamm
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

7.  The major herpes simplex virus DNA-binding protein holds single-stranded DNA in an extended configuration.

Authors:  W T Ruyechan
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

8.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.

Authors:  T Ooka; G M Lenoir; G Decaussin; G W Bornkamm; J Daillie
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

10.  DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein.

Authors:  J P Quinn; D J McGeoch
Journal:  Nucleic Acids Res       Date:  1985-11-25       Impact factor: 16.971

View more
  28 in total

1.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.

Authors:  A J Aguirre; E S Robertson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Epstein-Barr virus polymerase processivity factor enhances BALF2 promoter transcription as a coactivator for the BZLF1 immediate-early protein.

Authors:  Sanae Nakayama; Takayuki Murata; Kazutaka Murayama; Yoshihiro Yasui; Yoshitaka Sato; Ayumi Kudoh; Satoko Iwahori; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

5.  The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

Authors:  L D Strockbine; J I Cohen; T Farrah; S D Lyman; F Wagener; R F DuBose; R J Armitage; M K Spriggs
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.

Authors:  H B Jenson; G M Grant; Y Ench; P Heard; C A Thomas; S G Hilsenbeck; M P Moyer
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

7.  Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis.

Authors:  T R Serio; J L Kolman; G Miller
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Epstein-Barr virus vectors for gene delivery to B lymphocytes.

Authors:  E S Robertson; T Ooka; E D Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

9.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

10.  A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.

Authors:  Vladimir Majerciak; Wenjing Yang; Jing Zheng; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.